Earlier this month, The Trump administration launched TrumpRx.gov, a government website that allows consumers to purchase prescription drugs directly. The move is part of a broader overhaul of US pharmaceutical policy, which includes letters sent to 17 drugmakers demanding lower domestic prices and the enforcement of the Most Favoured Nation (MFN) (lowering US drug prices to those in other developed countries).



